Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2025)

Pulse Biosciences' (PLSE) quarterly Asset Utilization Ratio came in at 0.0 in Q3 2025, down 79.01% quarter-over-quarter from 0.0 in Q1 2023.

Pulse Biosciences (PLSE) Asset Utilization Ratio (2022 - 2025) Analysis & Trends

Pulse Biosciences' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.0 in Q3 2025; TTM through Sep 2025 was 0.0, a N/A change from a year earlier, with the FY2022 full-year figure at 0.01, down 63.35% from the prior year.
  • Asset Utilization Ratio declined to 0.0 in Q3 2025 per PLSE's latest filing, from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.05 in Q2 2022 and bottomed at 0.0 in Q3 2025.
  • The 3-year median for Asset Utilization Ratio is 0.01 (2022), against an average of 0.02.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 0.33
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 0.54
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 0.40
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 0.64
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 0.81
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 0.34
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 0.58
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 0.65
10 Pulse Biosciences 2.09 Bn 2.01 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 0.00
Mar 31, 2023 0.00
Dec 31, 2022 0.01
Sep 30, 2022 0.02
Jun 30, 2022 0.05